Haemonetics Corporation beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q12027 FY2027 | $1.07 | $1.14 | +6.5% | Beat |
| Q42026 FY2026 | $1.28 | $1.29 | +0.8% | Beat |
| Q32026 FY2026 | $1.27 | $1.31 | +3.1% | Beat |
Back to HAE overview · HAE holders · HAE KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.